Risk-Based Approaches to Post-Marketing Surveillance: Optimizing Resource Allocation January 25, 2026
Adverse Drug Reaction Reporting Patterns in Indian Healthcare Settings: A Meta-Analysis of Barriers and Facilitators January 24, 2026
Pharmacovigilance of Biosimilars in India: Regulatory Framework, Clinical Experience, and Future Directions January 24, 2026
